関連する実験動画
Updated: Jul 26, 2026

14:45
Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
Published on: August 6, 2014
男性の生殖線における病原性FGFR2変異の選択的優位性に関する証拠
Anne Goriely1, Gilean A T McVean, Maria Röjmyr
1Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK.
まとめ
人間の精子突然変異は父親の年齢とともに増加しますが,高いレベルは珍しい出来事から生じます. 逆説的に,有害なFGFR2変異は,精子産生細胞に優遇される可能性があります.
科学分野:
- 遺伝学とゲノミクス
- 人間の生殖と発達.
- 分子生物学は分子生物学である.
背景:
- 人間のゲメットの変異率は男性に偏り,父親の年齢とともに増加する.
- このバイアスの以前の説明には,複製エラーと非効率的なDNA修復が含まれています.
- これらの年齢に関連する突然変異の動態を直接的に研究することは,挑戦的でした.
研究 の 目的:
- 精子における特定の遺伝子変異を定量化するための敏感な方法を開発する.
- 父の年齢と,線維芽細胞成長因子受容体2 (FGFR2) 遺伝子の変異の関係について調べる.
- 変異の蓄積と潜在的な選択的圧力を駆動する根本的なメカニズムを探求する.
主な方法:
- 人間の精子内のFGFR2遺伝子の特定の部位 (位置755) での нуклеотиド置換を定量化するための敏感なアッセイを開発した.
- 父の年齢とこれらのFGFR2変異の頻度との相関を分析しました.
- 高頻度変異の起源を評価し,頻繁な変異イベントとまれな変異イベントを区別した.
主要な成果:
- 精子のFGFR2遺伝子のヌクレオチド755の置換レベルは,父親の年齢とともに増加する.
- 観察された高い突然変異の頻度でさえ,まれで特定の突然変異のイベントから派生しています.
- この研究では,FGFR2変異を携えた精子細胞の潜在的な選択的利点が特定されました.
結論:
- 精子におけるFGFR2変異の年齢関連の増加が確認され,稀なイベントから発生しています.
- 有害なFGFR2変異は,精子細胞に与えられた選択的優位性により,矛盾的に精子に濃縮される可能性があります.
- この発見は,雄性ゲメットの変異バイアスの基礎となるメカニズムに関する新しい視点を提供します.
関連する概念動画
X-linked Traits
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
Sex-linked Disorders
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
The Ratio of X Chromosome to Autosomes
In most organisms, sex is determined by the ratio of X and Y chromosomes. However, in some organisms, such as Drosophila and C.elegans, sex is determined by the ratio of the number of X chromosomes to the number of sets of autosomes. The Y chromosome in Drosophila is active but does not determine sex. It contains genes responsible for the production of sperms in adult flies.
Normal male Drosophila has a ratio of one X chromosome to two sets of autosomes. In contrast, normal female Drosophila...
Normal male Drosophila has a ratio of one X chromosome to two sets of autosomes. In contrast, normal female Drosophila...
Complementation Tests
A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

